Prof. Aryeh Tsavan, the president of the university, told Dr. Zaks in their conversation: "Through this degree, we wish to express the deep appreciation we have for each and every member of the dedicated and impressive team you lead, for your life-saving work, a work that brought deep hope to all the inhabitants of the world and a deep and special pride To all the citizens of Israel, who rightly see you as one of our own"
Bar-Ilan University will award an honorary doctorate this coming May to Dr. Tal Zaks, the medical director of the Moderna company who participated in the development of an innovative vaccine for the corona virus.
Prof. Aryeh Tsavan, the president of the university, told Dr. Sachs in a joint conversation between the two: "Not many times does one get to reap such historical fruits and meet in such an exciting way the tremendous impact of the actions of one's own hands. Your people and you have earned it. This title is our humble way of expressing the deep appreciation we have for each and every member of the dedicated and impressive team you lead, for your life-saving scientific work, a work that brought deep hope to all the inhabitants of the world and a deep and special pride to all the citizens of Israel, who rightly see you as one of our own."
Dr. Sachs said "I am excited and grateful to the selection committee. The work of my life and my life is expressed in the translation of science into medicine, a translation whose success depends on a combination of scientific excellence with moral insights. I am especially proud to receive the degree from Bar-Ilan University, since it represents for me the melting pot of this combination in a Jewish and Zionist aspect that is unique in the world and close to my heart."
Dr. Zaks, a graduate of the Reali School in Haifa, completed his medical studies at Ben Gurion University of the Negev in 1992. He did his internship inInternal medicine בTemple University and the subspecialty in the department Oncology בUniversity of Pennsylvania. In 2015, he began his position as the medical director of the biotechnology company Moderna.
The vaccine developed by Moderna is based on a technology known in the world of medicine from the 90s, but innovative in the world of vaccines. As part of the development of an mRNA-based vaccine against COVID19, Moderna was the first to enter a clinical trial already in March 2020 and turned this technology into a leading solution against the coronavirus.
In the reasons for the selection sent to Dr. Zaks, Prof. Tsavan added that "the degree committee, which chose you from among a long list of worthy and impressive candidates, expressed its deep admiration for the determination and courage that will distinguish your path and no less than the moral backbone, the personal example that you will contribute to the education of the future generation of The scientists and researchers. In your qualities, you embody the values of Bar-Ilan University and give us all great inspiration."
Bar-Ilan University has been awarding "Honorary Doctorate" degrees since 1971 to public figures, science, spirit and art, from Israel or abroad who stood out for their unique contribution to society and the country.
The honorary doctorate awarding ceremony will be held on Sunday the 30th in Sivan, Israel, May 2021, XNUMX, at the events of the university's board of trustees. The event is planned to take place physically, in the hope that thanks to the vaccination campaign that Dr. Zaks and his people contributed so much to its completion, it will be possible to take place physically on campus in the presence of members of the Bar Ilan community.
More of the topic in Hayadan:
One response
If he is a doctor who will say why there are many who suffer from heart disease after the second dose, how safe it is and why not take another dose, stop avoiding it, go to the forum and answer the questions